本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Inari Medical, Inc.

79.97
0.0000
成交量:- -
成交額:1.89億
市值:46.97億
市盈率:-59.05
高:79.97
開:79.97
低:79.97
收:79.97
資料載入中...
2025/02/19

交易所摘牌聲明

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
2025/02/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

員工持股計劃

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
2025/02/19

重要事件披露

Form 8-K - Current report
2025/01/06

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/06

重要事件披露

Form 8-K - Current report
2024/12/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/10/29

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/28

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/10/28

重要事件披露

Form 8-K - Current report
2024/09/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/19

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/07/30

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]